Results 71 to 80 of about 1,458 (206)

A prospective study of efficacy and safety of olopatadine versus azelastine in allergic conjunctivitis at a tertiary care hospital [PDF]

, 2017
Background: Allergic conjunctivitis, an ocular surface inflammatory disease with significant social and economic impact affects approximately 25% of the general population.
Vijayalakshmi, ., Nanthini R., C. R., Jayanthi, R., Nanthini, . Vijayalakshmi, Jayanthi C. R.   +5 more
core   +1 more source

P2 Receptors as Therapeutic Targets in Allergic Rhinitis: Insights From the Use of Natural Products and Preclinical Studies

Journal of Immunology Research, Volume 2026, Issue 1, 2026.
Allergic rhinitis (AR) is a chronic inflammatory disorder of the upper airways that is mediated by immunoglobulin E (IgE) and triggered by environmental allergens. Current pharmacological therapies, including antihistamines, corticosteroids, and immunotherapy, offer symptomatic relief but are limited by their incomplete disease‐modulating effects and ...
Thalita Calvet Pereira, Leandro Rocha, Robson Xavier Faria, Poorani Gurumallesh Prabu   +3 more
wiley   +1 more source

Ultrasound‐Guided Nerve Block: A Potential Intervention for Drug‐Refractory Allergic Rhinitis

Clinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Ultrasound‐guided sphenopalatine ganglion block presents a promising, minimally invasive intervention for patients with drug‐refractory allergic rhinitis. This case demonstrates its potential to achieve significant symptom relief and quality‐of‐life improvement with a favorable safety profile, offering an alternative when conventional ...
Ruimeng Tian, Sisi Nie, Changmei Kou, Meizu Wang, Shiyi Pu, Zhihai Li   +5 more
wiley   +1 more source

Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK‐air and EAACI Methodological Committee Report

Allergy, Volume 80, Issue 12, Page 3319-3330, December 2025.
This study compares different medications for allergic rhinitis on patients' satisfaction and co‐medication use frequency. mHealth data suggest that intranasal corticosteroids (INCS) and fixed combinations of intranasal antihistamines (INAH) and corticosteroids are associated with higher treatment satisfaction than oral antihistamines (OAH).
Bernardo Sousa‐Pinto, Rafael José Vieira, Antonio Bognanni, Matteo Martini, Michal Ordak, Giovanni Paoletti, Sara Gil‐Mata, Rita Amaral, Anna Bedbrook, Patrizia Bonadonna, Luisa Brussino, G. Walter Canonica, João Coutinho‐Almeida, Álvaro A. Cruz, Wienczyslawa Czarlewski, Mark Dykewicz, Mattia Giovannini, Bilun Gemicioglu, Juan Carlos Ivancevich, Ludger Klimek, Violeta Kvedariene, Desiree E. Larenas‐Linnemann, Manuel Marques‐Cruz, André Moreira, Marek Niedoszytko, Ana Margarida Pereira, Nikolaos G. Papadopoulos, Nhan Pham‐Thi, Frederico S. Regateiro, Sanna K. Toppila‐Salmi, Boleslaw Samolinski, Joaquin Sastre, Luís Taborda‐Barata, Tuuli Thomander, Ilgım Vardaloğlu Koyuncu, Arunas Valiulis, Leticia de las Vecillas, Maria Teresa Ventura, Jolanta Walusiak‐Skorupa, Yi‐Kui Xiang, Oliver Pfaar, João A. Fonseca, Torsten Zuberbier, Holger J. Schünemann, Danilo di Bona, Jean Bousquet   +45 more
wiley   +1 more source

A Randomized Prospective Open Label Comparative Study of Olopatadine with Sodium Cromoglycate in Allergic Conjunctivitis [PDF]

, 2017
BACKGROUND : Allergic conjunctivitis is the second most common cause of ocular morbidity in India and it accounts about20% of cases attending ophthalmology clinics. Ocular itching and nasal symptoms adversely affect the quality of life of patients. AIM
Sanu, Sain
core  

Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials [PDF]

, 2014
Introduction: The efficacy and safety of the once-daily topical ophthalmic solutions, alcaftadine 0.25% and olopatadine 0.2%, in preventing ocular itching associated with allergic conjunctivitis were evaluated.
David A. Hollander, Stacey L. Ackerman, Marsico, Nicholas P., Eugene B. McLaurin, Ciolino, Joseph, McLaurin, Eugene B., Ackerman, Stacey L., Villanueva, Linda, Williams, Julia M., Joseph B. Ciolino, Linda Villanueva, Nicholas P. Marsico, Julia M. Williams, Hollander, David A.   +13 more
core   +1 more source

Generalized Bullous Fixed Drug Eruption Secondary to Levocetirizine: A Lesson Learned!

Clinical Case Reports, Volume 13, Issue 11, November 2025.
ABSTRACT Fixed drug eruption (FDE) is a unique type of adverse drug eruption characterized by a well‐defined erythematous to violaceous patch that recurs at the same site upon re‐exposure to causative drugs and resolves with hyperpigmentation. This distinct drug reaction is a type IV hypersensitivity reaction that is mediated by memory CD8+ T cells ...
Mahesh Mathur, Sumit Paudel, Nabita Bhattarai, Sambidha Karki, Sandhya Regmi   +4 more
wiley   +1 more source

Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis

, 2003
Purpose: To compare the therapeutic effects of two ophthalmic solutions (0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine) with different pharmacological mechanisms on the clinical signs and Symptoms of seasonal allergic conjunctivitis (SAC)
Tatlıpınar, Sinan, Yaylalı, Volkan, Demirlenk, İbrahim, Özbay, Davut, Esme, Arif, Yıldırım, Cem, Özden, Serap   +6 more
core   +1 more source

Results of Observational Study and Integration of Epinastine 0,05% in Treatment Algorythms of Patients with Seasonal Allergic Conjunctivitis

Oftalʹmologiâ
Objective. To assess tolerability and the time of onset of clinical effect of dual­-action antihistamine agents — Epinepta® (epinastine 0.05 %) and olopatadine 0.1 % in patients with seasonal allergic conjunctivitis (SAC).Subjects and methods. This was a
D. Yu. Maychuk, E. A. Drozdova, A. A. Tarkhanova, E. E. Zinych   +3 more
doaj   +1 more source

ALLERGIC EYE DISEASES IN CHILDREN. MODERN VIEW ON PATHOGENESIS AND TREATMENT

Oftalʹmologiâ, 2017
The prevalence off allergic diseases has  been  significantly increased among  adults  and children during last 30-40 years. International study has  shown  that  the  frequency  of atopy  in developed  countries, including Russia,   is higher  than  in ...
E. Y. Markova, E. G. Polunina, E. E. Ioileva   +2 more
doaj   +1 more source